Shinji Kobuchi

Therapeutic Drug Monitoring of Vancomycin in Dermal Interstitial Fluid Using Dissolving Microneedles

Yuto Inagaki, Shinji Kobuchi, Kanji Takada et al. · International Journal of Medical Sciences · 2016 · 60 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +13

A validated LC‐MS/MS method for the determination of canagliflozin, a sodium–glucose co‐transporter 2 (SGLT‐2) inhibitor, in a lower volume of rat plasma: application to pharmacokinetic studies in rats

Shinji Kobuchi, Kyoka Yano, Toshiyuki Sakaeda · Biomedical Chromatography · 2016 · 39 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Susceptibility to serious skin and subcutaneous tissue disorders and skin tissue distribution of sodium-dependent glucose co-transporter type 2 (SGLT2) inhibitors

Toshiyuki Sakaeda, Shinji Kobuchi, Ryosuke Yoshioka et al. · International Journal of Medical Sciences · 2018 · 36 citations · Full text

Medicine, Dermatology, Pharmacology +13

Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer

Keiko Nakao, Shinji Kobuchi, Shuhei Marutani et al. · Scientific Reports · 2019 · 36 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Circadian variations in the pharmacokinetics of capecitabine and its metabolites in rats

Shinji Kobuchi, Yukiko Yazaki, Toshiyuki Sakaeda · European Journal of Pharmaceutical Sciences · 2017 · 27 citations

Nursing, Pharmacokinetics, Pharmacology +10